Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00303914 · ClinicalTrials.gov registry record

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

A clinical trial, sponsored by Eastern Cooperative Oncology Group.

Completed
Registry status
2,310
Enrollment target

NCT00303914 is a clinical trial that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 2,310 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00303914 has completed, sponsored by Eastern Cooperative Oncology Group.

COMPLETED
Registry status
2,310 participants
Enrollment target

Study Summary

RATIONALE: Questionnaires that assess symptoms caused by cancer and cancer therapy may help improve the ability to plan treatment for patients with invasive cancer to help them live longer and more comfortably. PURPOSE: This clinical trial is studying symptoms caused by cancer and cancer therapy in patients with invasive breast, lung, prostate, or colorectal cancer.

Interventions

  • PROCEDURE cognitive assessment
  • PROCEDURE psychosocial assessment and care
  • PROCEDURE assessment of therapy complications

Trial Details

FieldValue
Enrollment Target 2,310 participants
Start Date 2006-03-14
Est. Completion 2013-03-04

Sponsor

Eastern Cooperative Oncology Group

141 total trials

What the Registry Record Tells You About NCT00303914

The ClinicalTrials.gov registry entry for NCT00303914 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,310 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which cognitive assessment is the first listed.

NCT00303914 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00303914 about?

NCT00303914 is a clinical study titled "Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer". RATIONALE: Questionnaires that assess symptoms caused by cancer and cancer therapy may help improve the ability to plan treatment for patients with invasive cancer to help them live longer and more comfortably. PURPOSE: This clinical trial is studying symptoms caused by cancer and cancer therapy in...

What is the current status of trial NCT00303914?

This trial is currently completed. The enrollment target is 2,310 participants. The study started on 2006-03-14. Estimated completion is 2013-03-04.

What interventions are being tested in trial NCT00303914?

The interventions under investigation include: cognitive assessment (PROCEDURE), psychosocial assessment and care (PROCEDURE), assessment of therapy complications (PROCEDURE).

Who is sponsoring clinical trial NCT00303914?

This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.